Physician profile
Donna Feldman
NPI 1871579003
$1,151.80
in general payments reported to CMS, 2019-2025
19 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $39.85 · 2021: $243 · 2022: $52.05 · 2023: $120 · 2024: $87.45 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $327.93 | 2019-2024 | |
| Amgen INC. | $176.11 | 2019-2025 | |
| Astellas Pharma US INC | $124.77 | 2019-2024 | Veozah, Myrbetriq |
| Lilly USA, LLC | $109.44 | 2025 | Zepbound |
| Abbvie INC. | $66.05 | 2019-2021 | |
| Hologic Sales and Service, LLC | $53.07 | 2019-2024 | Aptima |
| Merck Sharp & Dohme LLC | $42.47 | 2019 | |
| Allergan, INC. | $41.22 | 2019-2020 | |
| Pfizer INC. | $31.22 | 2021 | |
| Ge Healthcare | $30.00 | 2021 | |
| Daiichi Sankyo INC. | $23.38 | 2023 | Injectafer |
| Novo Nordisk INC | $21.04 | 2025 | |
| Olympus America INC. | $17.93 | 2019 | |
| Sumitomo Pharma America, INC. | $17.46 | 2023 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $16.47 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $14.07 | 2019 | |
| Agile Therapeutics, INC. | $13.43 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.19 | 2020 | |
| Mayne Pharma Commercial LLC | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.